Ratiometric real-time monitoring of hydroxyapatite–doxorubicin nanotheranostic agents for on-demand tumor targeted chemotherapy
Journal article published in 2018 by
Yao Kang,
Wen Sun,
Jiangli Fan 
,
Zimu Wei ,
Suzhen Wang,
Mingle Li,
Zhen Zhang,
Yahui Xie,
Jianjun Du ,
Xiaojun Peng
,
Zimu Wei ,
Suzhen Wang,
Mingle Li,
Zhen Zhang,
Yahui Xie,
Jianjun Du ,
Xiaojun Peng
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 
Abstract
Hydroxyapatite–doxorubicin nanotheranostic agents are used for tumor-targeted chemotherapy, providing a platform for ratiometric real-time tracking of drug release.